Soleno Therapeutics Inc banner

Soleno Therapeutics Inc
NASDAQ:SLNO

Watchlist Manager
Soleno Therapeutics Inc Logo
Soleno Therapeutics Inc
NASDAQ:SLNO
Watchlist
Price: 53.01 USD Market Closed
Market Cap: $2.8B

Wall St Price Targets

SLNO Price Targets Summary
Soleno Therapeutics Inc

Wall Street analysts forecast SLNO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SLNO is 57.53 USD with a low forecast of 53.53 USD and a high forecast of 84 USD.

Lowest Forecast
Price Target
53.53 USD
1% Upside
Average Forecast
Price Target
57.53 USD
9% Upside
Highest Forecast
Price Target
84 USD
58% Upside
Soleno Therapeutics Inc Competitors:
Price Targets
NNOX
Nano-X Imaging Ltd
251% Upside
ORLY
O'Reilly Automotive Inc
23% Upside

Revenue
Forecast

41% / Year
Past Growth
75% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
41% / Year
Past Growth
75% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 12 years, the compound annual growth rate for Revenue has been 41%. The projected CAGR for the next 3 years is 75%.

Operating Income
Forecast

N/A
Past Growth
307% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
N/A
Past Growth
307% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

The compound annual growth rate for Operating Income over the next 3 years is 307%.

Net Income
Forecast

N/A
Past Growth
188% / Year
Estimated Growth
Estimates Accuracy
-93%
Average Miss
N/A
Past Growth
188% / Year
Estimated Growth
Estimates Accuracy
-93%
Average Miss

The compound annual growth rate for Net Income over the next 3 years is 188%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is SLNO's stock price target?
Price Target
57.53 USD

According to Wall Street analysts, the average 1-year price target for SLNO is 57.53 USD with a low forecast of 53.53 USD and a high forecast of 84 USD.

What is the Revenue forecast for Soleno Therapeutics Inc?
Projected CAGR
75%

Over the last 12 years, the compound annual growth rate for Revenue has been 41%. The projected CAGR for the next 3 years is 75%.

What is the Operating Income forecast for Soleno Therapeutics Inc?
Projected CAGR
307%

The compound annual growth rate for Operating Income over the next 3 years is 307%.

What is the Net Income forecast for Soleno Therapeutics Inc?
Projected CAGR
188%

The compound annual growth rate for Net Income over the next 3 years is 188%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett